PODCAST · science
Therapeutic Science and Strategy
by Lumanity
In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.
Episodes
-
Playing Nicely with Friends: How to Make Choices on Portfolio Co-positioning
Pharma portfolios can create powerful opportunities, but without clear positioning, brands can end up competing with each other. In this episode, Lumanity's Jakub Kaczor, VP, Strategy Consulting, and Peter Smith, SVP, Strategy Consulting, discuss the complexities of portfolio positioning in the...
-
Policy Convergence and the Future of Pharma Value Creation with Steve Mather and Outcomes Rocket
In the volatility caused by policy convergence, the future belongs to organizations that can intelligently navigate inflection points that precede launch In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity discusses how policy shifts are converging to compress...
-
Building a Scalable Pharma Launch Engine that Drives Competitive Advantage
Most pharma launch frameworks don't fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity's Launch Excellence Project Lead, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical...
-
From Chaos to Confidence: Mastering Pharma Launch as a First-Time Team
Launching a pharma product is a high-stakes, pressure-filled marathon where poor planning shows up too late to fix. In this episode, Andrew Mooney and Laurence Cooper break down how early planning, focused strategy, and disciplined execution help smaller pharma teams succeed in high-pressure...
-
The Positioning Compass: Guiding Pharma Brands from Pipeline to Market
Great pharma brands don't wait for the market to define them; they define themselves through clear, early, and evolving positioning. In this episode, Vice President Natalie Thovmasian and Managing Consultant Liv Yates, highlight that brand positioning is a strategic driver across the entire…
more -
The Health Gap: Confronting Barriers to Care in Marginalized Communities
In the third episode of our Patient Progress podcast series, we look at the hidden and not-so-hidden barriers that keep marginalized communities from getting the mental and physical healthcare they need. Advocates Sarah Renee and Daniel Newman join host Jenny Payne for a candid conversation about...
-
Patient Progress: Barriers to Care: How Access and Affordability Shape Mental Illness Outcomes
In Episode 2 of our Patient Progress podcast series, we hear directly from those living with mental illness about the obstacles they face: the cost of care, insurance hurdles, and the lack of consistent support services that can mean the difference between getting well and going without.…
more -
Beyond the Data: Building Real Competitive Readiness
During this conversation with Outcomes Rocket, Sandy Richardson and Zoe Brown, Principals at Lumanity, talk about why organizations struggle to turn massive amounts of competitive intelligence into actionable strategy. In part 2, Sandy and Zoe discuss how companies can move beyond information...
-
Fixing Care Breakdowns Through Data, Behavioral Science, and Human Touch
During this conversation, Sandy Richardson and Zoe Brown, Principals at Lumanity, talk about why organizations struggle to turn massive amounts of competitive intelligence into actionable strategy. In part 1, Sandy and Zoe explain how today's "sea of sameness" makes true differentiation harder…
more -
Patient Progress: Mental Health in Caregivers
Caregivers are often the unsung heroes of healthcare: key decision‑makers, advocates, researchers, and emotional anchors. Yet, support for their own mental health is frequently absent. In this episode, Lumanity's Jenny Payne sits down with Ashlee Cramer and Ceinwen Giles to break misconceptions...
-
Key Oncology Takeaways from ESMO 2024
During this episode, Lumanity experts Rob Rawlinson and Kate Goacher discuss insights and takeaways from their recent attendance at the 2024 European Society for Medical Oncology (ESMO) conference. Their conversation covers a variety of topics, including: The importance of the patient and…
more -
Embracing the Pediatric Voice from Childhood Through Young Adulthood: Elevated Insights that Fuel Your Brands' Needs
In this episode, we talk about the concerns, misconceptions, and the value of engaging directly with and including the pediatric voice in market research
-
Communications Testing Research: Unlock the Power of Behaviour Change
In our latest Lumanity bitesize podcast, we explore how to avoid the common challenges and pitfalls encountered in communication testing research, and share best practices in applying a behavioural science lens to bring about stakeholder behaviour change. Our discussion includes: The importance…
more -
Supporting Rare Disease Communities
In this special podcast episode in honor of Rare Disease Day 2024, Angela Wheeler, President of Insight at Lumanity and Dr. Karin Hoelzer, Director of Policy and Regulatory Affairs at the National Organization for Rare Disorders (NORD), discuss opportunities for pharmaceutical companies to work...
-
Making Social Media Listening Insights Count: Live or Let Die
In this podcast episode, we explore the rich potential of social media listening (SML) insights, and how, when interpreted and acted on, they can have a significant impact on commercial decision-making. Hear from Lumanity experts as they bring SML to life using several real world examples. Topics...
-
Ensuring the Responsible and Meaningful Use of Generative AI in Healthcare Market Research
In this podcast episode, we explore the fascinating world of artificial intelligence and its impact on the healthcare industry, as well as the ever evolving realm of research and its potentially transformative power on decision making. Hear from Lumanity experts Damian Eade, Head of Digital...
-
The Importance of RWE Strategy Planning
There are incredible synergies with joint HEOR and Real World Evidence (RWE) projects, but there are also unique challenges. In this podcast episode, The Importance of RWE Strategy Planning, Ann-Marie Chapman, Nikita Jeswani, Meena Venkatachalam, and Alex Thorel discuss the use cases and planning...
-
Launch Excellence Alchemy: Managing Strategic Risk
Strategic risk is often overlooked within the pharmaceutical industry. There's a perception that someone else is picking up the risk ball. Or there is more of a focus on internal risks, with little thought to the larger external factors that can have a significant impact on your launch. We see...
-
Launch Excellence Alchemy: Mindset, Leadership, and the Value of a 'Third Voice'
We know that effective collaboration across cross-functional and global/local launch teams is one of the critical elements to launch success – but teams often struggle to develop the right behaviors that foster a truly collaborative culture. Leadership styles too play a vital role, with research...
-
Possible Implications of the Inflation Reduction Act for Oncology Products and Stakeholders
In this episode, Dr. Nancy McGee and Rob Rawlinson discuss potential implications of the Inflation Reduction Act (IRA) legislation that was passed in the U.S. in 2022. This episode covers: An overview of the IRA in relation to healthcare The potential impacts for oncology patients, manufacturers,...
-
Launch Excellence Alchemy: Who Cares Wins
During the launch of a new medicine, there is so much focus on the intellectual strategy, that it's easy to sideline thoughts about "How are we going to collaborate as a team to make this happen?" But statistics show that strong teamwork can deliver up to 3x more shareholder value. Investing time...
-
Discussion with the CEO and CMO of ImCheck
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead at Lumanity, sits down to talk about relevant and important content. In this sixth episode, Joel sits down with the CEO and CMO of ImCheck Therapeutics to discuss: Company origins, focus, and fundraising performance to date...
-
Tailored Treatment Algorithms, Liquid Biopsy, and Personalized Medicine
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this fifth episode, Joel sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean's Professor of...
-
A Look Beyond: Scientific, Clinical, and Commercial Considerations in Post-Checkpoint Solid Tumor Settings
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this fourth episode, Joel sits down with Jeff Bockman, Executive Vice President and Head of Oncology at Lumanity, and Michael Curran, PhD, Associate Professor,...
-
Changing the Narrative: The Story of an Ultra-rare Cancer Patient
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this third episode, Joel sits down with Michael 'Mitch' Petrick, anaplastic thyroid cancer patient, to explore: Mitch's background and his rare form of thyroid...
-
CAR-T in Solid Tumors: A Cancer Progress Sneak Peek
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center, to explore…
more -
Not So Rare: Win-wins in Ultra-orphan Diseases
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
Loading similar podcasts...
Frequently Asked Questions
How many episodes does Therapeutic Science and Strategy have?
Therapeutic Science and Strategy currently has 27 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is Therapeutic Science and Strategy about?
In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.
How often does Therapeutic Science and Strategy release new episodes?
Therapeutic Science and Strategy has 27 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to Therapeutic Science and Strategy?
You can listen to Therapeutic Science and Strategy on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts Therapeutic Science and Strategy?
Therapeutic Science and Strategy is created and hosted by Lumanity.
URL copied to clipboard!